1 Market Overview of Chronic Thromboembolic Pulmonary Hypertension 1.1 Chronic Thromboembolic Pulmonary Hypertension Market Overview 1.1.1 Chronic Thromboembolic Pulmonary Hypertension Product Scope 1.1.2 Chronic Thromboembolic Pulmonary Hypertension Market Status and Outlook 1.2 Global Chronic Thromboembolic Pulmonary Hypertension Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Region (2016-2027) 1.4 Global Chronic Thromboembolic Pulmonary Hypertension Historic Market Size by Region (2016-2021) 1.5 Global Chronic Thromboembolic Pulmonary Hypertension Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) 1.6.1 North America Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) 1.6.2 Europe Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) 1.6.3 Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) 1.6.4 Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) 1.6.5 Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) 2 Chronic Thromboembolic Pulmonary Hypertension Market Overview by Type 2.1 Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Chronic Thromboembolic Pulmonary Hypertension Historic Market Size by Type (2016-2021) 2.3 Global Chronic Thromboembolic Pulmonary Hypertension Forecasted Market Size by Type (2022-2027) 2.4 Transthoracic Echocardiogram (TTE) 2.5 Ventilation-Perfusion (V/Q) Scan 2.6 Pulmonary Angiography 2.7 Heart Catheterization 2.8 Computed Tomography (CT) Pulmonary Angiography 2.9 Others 3 Chronic Thromboembolic Pulmonary Hypertension Market Overview by Application 3.1 Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Chronic Thromboembolic Pulmonary Hypertension Historic Market Size by Application (2016-2021) 3.3 Global Chronic Thromboembolic Pulmonary Hypertension Forecasted Market Size by Application (2022-2027) 3.4 Hospitals 3.5 Ambulatory Surgical Centers 3.6 Others 4 Chronic Thromboembolic Pulmonary Hypertension Competition Analysis by Players 4.1 Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chronic Thromboembolic Pulmonary Hypertension as of 2020) 4.3 Date of Key Players Enter into Chronic Thromboembolic Pulmonary Hypertension Market 4.4 Global Top Players Chronic Thromboembolic Pulmonary Hypertension Headquarters and Area Served 4.5 Key Players Chronic Thromboembolic Pulmonary Hypertension Product Solution and Service 4.6 Competitive Status 4.6.1 Chronic Thromboembolic Pulmonary Hypertension Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Bayer 5.1.1 Bayer Profile 5.1.2 Bayer Main Business 5.1.3 Bayer Chronic Thromboembolic Pulmonary Hypertension Products, Services and Solutions 5.1.4 Bayer Chronic Thromboembolic Pulmonary Hypertension Revenue (US$ Million) & (2016-2021) 5.1.5 Bayer Recent Developments 5.2 Johnson & Johnson 5.2.1 Johnson & Johnson Profile 5.2.2 Johnson & Johnson Main Business 5.2.3 Johnson & Johnson Chronic Thromboembolic Pulmonary Hypertension Products, Services and Solutions 5.2.4 Johnson & Johnson Chronic Thromboembolic Pulmonary Hypertension Revenue (US$ Million) & (2016-2021) 5.2.5 Johnson & Johnson Recent Developments 5.3 Nippon Shinyaku 5.3.1 Nippon Shinyaku Profile 5.3.2 Nippon Shinyaku Main Business 5.3.3 Nippon Shinyaku Chronic Thromboembolic Pulmonary Hypertension Products, Services and Solutions 5.3.4 Nippon Shinyaku Chronic Thromboembolic Pulmonary Hypertension Revenue (US$ Million) & (2016-2021) 5.3.5 GlaxoSmithKline Recent Developments 5.4 GlaxoSmithKline 5.4.1 GlaxoSmithKline Profile 5.4.2 GlaxoSmithKline Main Business 5.4.3 GlaxoSmithKline Chronic Thromboembolic Pulmonary Hypertension Products, Services and Solutions 5.4.4 GlaxoSmithKline Chronic Thromboembolic Pulmonary Hypertension Revenue (US$ Million) & (2016-2021) 5.4.5 GlaxoSmithKline Recent Developments 5.5 Sun Pharmaceutical Industries 5.5.1 Sun Pharmaceutical Industries Profile 5.5.2 Sun Pharmaceutical Industries Main Business 5.5.3 Sun Pharmaceutical Industries Chronic Thromboembolic Pulmonary Hypertension Products, Services and Solutions 5.5.4 Sun Pharmaceutical Industries Chronic Thromboembolic Pulmonary Hypertension Revenue (US$ Million) & (2016-2021) 5.5.5 Sun Pharmaceutical Industries Recent Developments 5.6 Scipharm SaRL 5.6.1 Scipharm SaRL Profile 5.6.2 Scipharm SaRL Main Business 5.6.3 Scipharm SaRL Chronic Thromboembolic Pulmonary Hypertension Products, Services and Solutions 5.6.4 Scipharm SaRL Chronic Thromboembolic Pulmonary Hypertension Revenue (US$ Million) & (2016-2021) 5.6.5 Scipharm SaRL Recent Developments 5.7 Promedica International 5.7.1 Promedica International Profile 5.7.2 Promedica International Main Business 5.7.3 Promedica International Chronic Thromboembolic Pulmonary Hypertension Products, Services and Solutions 5.7.4 Promedica International Chronic Thromboembolic Pulmonary Hypertension Revenue (US$ Million) & (2016-2021) 5.7.5 Promedica International Recent Developments 5.8 Medical Research Network 5.8.1 Medical Research Network Profile 5.8.2 Medical Research Network Main Business 5.8.3 Medical Research Network Chronic Thromboembolic Pulmonary Hypertension Products, Services and Solutions 5.8.4 Medical Research Network Chronic Thromboembolic Pulmonary Hypertension Revenue (US$ Million) & (2016-2021) 5.8.5 Medical Research Network Recent Developments 5.9 Gilead Sciences 5.9.1 Gilead Sciences Profile 5.9.2 Gilead Sciences Main Business 5.9.3 Gilead Sciences Chronic Thromboembolic Pulmonary Hypertension Products, Services and Solutions 5.9.4 Gilead Sciences Chronic Thromboembolic Pulmonary Hypertension Revenue (US$ Million) & (2016-2021) 5.9.5 Gilead Sciences Recent Developments 5.10 Daiichi Sankyo 5.10.1 Daiichi Sankyo Profile 5.10.2 Daiichi Sankyo Main Business 5.10.3 Daiichi Sankyo Chronic Thromboembolic Pulmonary Hypertension Products, Services and Solutions 5.10.4 Daiichi Sankyo Chronic Thromboembolic Pulmonary Hypertension Revenue (US$ Million) & (2016-2021) 5.10.5 Daiichi Sankyo Recent Developments 6 North America 6.1 North America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Chronic Thromboembolic Pulmonary Hypertension Market Dynamics 11.1 Chronic Thromboembolic Pulmonary Hypertension Industry Trends 11.2 Chronic Thromboembolic Pulmonary Hypertension Market Drivers 11.3 Chronic Thromboembolic Pulmonary Hypertension Market Challenges 11.4 Chronic Thromboembolic Pulmonary Hypertension Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Chronic Thromboembolic Pulmonary Hypertension Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Chronic Thromboembolic Pulmonary Hypertension Market Size Share by Region (2016-2021) Table 4. Global Chronic Thromboembolic Pulmonary Hypertension Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Chronic Thromboembolic Pulmonary Hypertension Forecasted Market Size Share by Region (2022-2027) Table 6. Global Chronic Thromboembolic Pulmonary Hypertension Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Chronic Thromboembolic Pulmonary Hypertension Revenue Market Share by Type (2016-2021) Table 9. Global Chronic Thromboembolic Pulmonary Hypertension Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Chronic Thromboembolic Pulmonary Hypertension Revenue Market Share by Type (2022-2027) Table 11. Global Chronic Thromboembolic Pulmonary Hypertension Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Chronic Thromboembolic Pulmonary Hypertension Revenue Market Share by Application (2016-2021) Table 14. Global Chronic Thromboembolic Pulmonary Hypertension Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Chronic Thromboembolic Pulmonary Hypertension Revenue Market Share by Application (2022-2027) Table 16. Global Chronic Thromboembolic Pulmonary Hypertension Revenue (US$ Million) by Players (2016-2021) Table 17. Global Chronic Thromboembolic Pulmonary Hypertension Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chronic Thromboembolic Pulmonary Hypertension as of 2020) Table 19. Date of Key Manufacturers Enter into Chronic Thromboembolic Pulmonary Hypertension Market Table 20. Global Chronic Thromboembolic Pulmonary Hypertension Top Players Headquarters and Area Served Table 21. Chronic Thromboembolic Pulmonary Hypertension Product Solution and Service Table 22. Global Chronic Thromboembolic Pulmonary Hypertension Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Bayer Basic Information List Table 25. Bayer Description and Business Overview Table 26. Bayer Chronic Thromboembolic Pulmonary Hypertension Products, Services and Solutions Table 27. Revenue (US$ Million) in Chronic Thromboembolic Pulmonary Hypertension Business of Bayer (2016-2021) Table 28. Bayer Recent Developments Table 29. Johnson & Johnson Basic Information List Table 30. Johnson & Johnson Description and Business Overview Table 31. Johnson & Johnson Chronic Thromboembolic Pulmonary Hypertension Products, Services and Solutions Table 32. Revenue (US$ Million) in Chronic Thromboembolic Pulmonary Hypertension Business of Johnson & Johnson (2016-2021) Table 33. Johnson & Johnson Recent Developments Table 34. Nippon Shinyaku Basic Information List Table 35. Nippon Shinyaku Description and Business Overview Table 36. Nippon Shinyaku Chronic Thromboembolic Pulmonary Hypertension Products, Services and Solutions Table 37. Revenue (US$ Million) in Chronic Thromboembolic Pulmonary Hypertension Business of Nippon Shinyaku (2016-2021) Table 38. Nippon Shinyaku Recent Developments Table 39. GlaxoSmithKline Basic Information List Table 40. GlaxoSmithKline Description and Business Overview Table 41. GlaxoSmithKline Chronic Thromboembolic Pulmonary Hypertension Products, Services and Solutions Table 42. Revenue (US$ Million) in Chronic Thromboembolic Pulmonary Hypertension Business of GlaxoSmithKline (2016-2021) Table 43. GlaxoSmithKline Recent Developments Table 44. Sun Pharmaceutical Industries Basic Information List Table 45. Sun Pharmaceutical Industries Description and Business Overview Table 46. Sun Pharmaceutical Industries Chronic Thromboembolic Pulmonary Hypertension Products, Services and Solutions Table 47. Revenue (US$ Million) in Chronic Thromboembolic Pulmonary Hypertension Business of Sun Pharmaceutical Industries (2016-2021) Table 48. Sun Pharmaceutical Industries Recent Developments Table 49. Scipharm SaRL Basic Information List Table 50. Scipharm SaRL Description and Business Overview Table 51. Scipharm SaRL Chronic Thromboembolic Pulmonary Hypertension Products, Services and Solutions Table 52. Revenue (US$ Million) in Chronic Thromboembolic Pulmonary Hypertension Business of Scipharm SaRL (2016-2021) Table 53. Scipharm SaRL Recent Developments Table 54. Promedica International Basic Information List Table 55. Promedica International Description and Business Overview Table 56. Promedica International Chronic Thromboembolic Pulmonary Hypertension Products, Services and Solutions Table 57. Revenue (US$ Million) in Chronic Thromboembolic Pulmonary Hypertension Business of Promedica International (2016-2021) Table 58. Promedica International Recent Developments Table 59. Medical Research Network Basic Information List Table 60. Medical Research Network Description and Business Overview Table 61. Medical Research Network Chronic Thromboembolic Pulmonary Hypertension Products, Services and Solutions Table 62. Revenue (US$ Million) in Chronic Thromboembolic Pulmonary Hypertension Business of Medical Research Network (2016-2021) Table 63. Medical Research Network Recent Developments Table 64. Gilead Sciences Basic Information List Table 65. Gilead Sciences Description and Business Overview Table 66. Gilead Sciences Chronic Thromboembolic Pulmonary Hypertension Products, Services and Solutions Table 67. Revenue (US$ Million) in Chronic Thromboembolic Pulmonary Hypertension Business of Gilead Sciences (2016-2021) Table 68. Gilead Sciences Recent Developments Table 69. Daiichi Sankyo Basic Information List Table 70. Daiichi Sankyo Description and Business Overview Table 71. Daiichi Sankyo Chronic Thromboembolic Pulmonary Hypertension Products, Services and Solutions Table 72. Revenue (US$ Million) in Chronic Thromboembolic Pulmonary Hypertension Business of Daiichi Sankyo (2016-2021) Table 73. Daiichi Sankyo Recent Developments Table 74. North America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2016-2021) & (US$ Million) Table 75. North America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2022-2027) & (US$ Million) Table 76. Europe Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2016-2021) & (US$ Million) Table 77. Europe Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2022-2027) & (US$ Million) Table 78. Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Size by Region (2016-2021) & (US$ Million) Table 79. Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Size by Region (2022-2027) & (US$ Million) Table 80. Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Share by Region (2016-2021) Table 81. Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Share by Region (2022-2027) Table 82. Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2016-2021) & (US$ Million) Table 83. Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2022-2027) & (US$ Million) Table 84. Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Size by Players (2016-2021) & (US$ Million) Table 85. Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2022-2027) & (US$ Million) Table 86. Chronic Thromboembolic Pulmonary Hypertension Market Trends Table 87. Chronic Thromboembolic Pulmonary Hypertension Market Drivers Table 88. Chronic Thromboembolic Pulmonary Hypertension Market Challenges Table 89. Chronic Thromboembolic Pulmonary Hypertension Market Restraints Table 90. Research Programs/Design for This Report Table 91. Key Data Information from Secondary Sources Table 92. Key Data Information from Primary Sources List of Figures Figure 1. Global Chronic Thromboembolic Pulmonary Hypertension Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Chronic Thromboembolic Pulmonary Hypertension Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Regions: 2021 VS 2027 Figure 4. Global Chronic Thromboembolic Pulmonary Hypertension Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Chronic Thromboembolic Pulmonary Hypertension Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Chronic Thromboembolic Pulmonary Hypertension Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Chronic Thromboembolic Pulmonary Hypertension Market Size Share by Type in 2021 & 2027 Figure 11. Transthoracic Echocardiogram (TTE) Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Ventilation-Perfusion (V/Q) Scan Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Pulmonary Angiography Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Heart Catheterization Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Computed Tomography (CT) Pulmonary Angiography Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Others Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Global Chronic Thromboembolic Pulmonary Hypertension Market Size Share by Application in 2021 & 2027 Figure 18. Hospitals Market Size (US$ Million) YoY Growth (2016-2027) Figure 19. Ambulatory Surgical Centers Market Size (US$ Million) YoY Growth (2016-2027) Figure 20. Others Market Size (US$ Million) YoY Growth (2016-2027) Figure 21. Chronic Thromboembolic Pulmonary Hypertension Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 22. Global Top 5 and Top 10 Players Chronic Thromboembolic Pulmonary Hypertension Market Share in 2020 Figure 23. North America Chronic Thromboembolic Pulmonary Hypertension Market Share by Country (2016-2027) Figure 24. United States Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 25. Canada Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 26. Germany Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 27. France Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 28. U.K. Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 29. Italy Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 30. Russia Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 31. Nordic Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 32. Rest of Europe Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 33. Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Share by Region (2016-2027) Figure 34. China Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 35. Japan Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 36. South Korea Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 37. Southeast Asia Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 38. India Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 39. Australia Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 40. Rest of Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 41. Latin America Chronic Thromboembolic Pulmonary Hypertension Market Share by Country (2016-2027) Figure 42. Mexico Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 43. Brazil Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 44. Rest of Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 45. Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Share by Country (2016-2027) Figure 46. Turkey Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 47. Saudi Arabia Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 48. UAE Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 49. Rest of Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Size (2016-2027) & (US$ Million) Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation

Bayer Johnson & Johnson Nippon Shinyaku GlaxoSmithKline Sun Pharmaceutical Industries Scipharm SaRL Promedica International Medical Research Network Gilead Sciences Daiichi Sankyo